GH as of Oct 31 · 10:11 ET
GHNasdaqServices-Medical Laboratories
Guardant Health, Inc. · Brief
Next report
4 days
Nov 4 · after closeest.Q3 FY26
Expected move
Inputs1 of 8≥ implied
- avg implied
- ±11.5%
- avg realized
- ±8.2%
Feb 20 '25±11.7%▼−9.56%×0.82
Apr 30 '25±13.0%▲+3.47%×0.27
Jul 30 '25±13.2%▼−9.32%×0.71
Oct 29 '25±12.5%▲+27.87%×2.22
Jan 12 '26±7.4%▼−2.36%×0.32
Feb 19 '26±9.5%▼−3.08%×0.32
Q1 FY26±11.8%▲+3.73%×0.32
Q2 FY26±12.9%▲+6.33%×0.49
quarterimplied−30%0+30%realized×
Q2 FY26±12.9%▲+6.33%×0.49
Q1 FY26±11.8%▲+3.73%×0.32
Feb '26±9.5%▼−3.08%×0.32
Jan '26±7.4%▼−2.36%×0.32
Oct '25±12.5%▲+27.87%×2.22
Jul '25±13.2%▼−9.32%×0.71
2 older reports
Apr '25±13.0%▲+3.47%×0.27
Feb '25±11.7%▼−9.56%×0.82
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close
Bull & bear
Nov 4 report · est.Bull2
Bear2 of 4
−9.19%change in shares held by the ten largest reporting managers over the latest quarter13F · Jun 30 '26
AI captions · Sep 16 '26once per report · top 2 per case
Linked exposure
GH report sessionSuppliers 1
× = co-movement · max 501dSource: SEC filings · market data
Your note
privateThesis 0 · Decisions 0 · Observations 0
No thesis.